Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06516757 · ClinicalTrials.gov registry record · NA
A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.
A NA study, sponsored by Love Wellness.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06516757 is a NA study that has completed, run by Love Wellness. The registered enrollment target is 40 participants.
The verdict
NCT06516757, a NA study, has completed, sponsored by Love Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a virtual single-group clinical trial that will last 12 weeks. Participants will use The Killer® (Boric Acid Suppositories) once daily for 7 consecutive days when they feel that they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching. Participants will complete a questionnaire before using the product and on Days 3 and 7 of using the product. They will also complete a vaginal swab pH test before using the product and after 7 days of using the product (Day 8).
Interventions
- DIETARY_SUPPLEMENT Boric Acid Suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2024-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06516757
The ClinicalTrials.gov registry entry for NCT06516757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Love Wellness, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Boric Acid Suppository is the first listed.
NCT06516757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06516757 about?
NCT06516757 is a clinical study titled "A Single Group Study to Evaluate the Effects of a Boric Acid Suppository on Vaginal Health.". This is a virtual single-group clinical trial that will last 12 weeks. Participants will use The Killer® (Boric Acid Suppositories) once daily for 7 consecutive days when they feel that they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/o...
What is the current status of trial NCT06516757?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-04-05. Estimated completion is 2024-07-05.
What interventions are being tested in trial NCT06516757?
The interventions under investigation include: Boric Acid Suppository (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06516757?
This trial is sponsored by Love Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.